NKp46‐specific single domain antibodies enable facile engineering of various potent NK cell engager formats

por Lipinski, Britta, Arras, Paul, Pekar, Lukas, Klewinghaus, Daniel, Boje, Ammelie Svea, Krah, Simon, Zimmermann, Jasmin, Klausz, Katja, Peipp, Matthias, Siegmund, Vanessa, Evers, Andreas, Zielonka, Stefan
Publicado 2023

Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display

por Krohn, Steffen, Boje, Ammelie Svea, Gehlert, Carina Lynn, Lutz, Sebastian, Darzentas, Nikos, Knecht, Henrik, Herrmann, Dietrich, Brüggemann, Monika, Scheidig, Axel J., Weisel, Katja, Gramatzki, Martin, Peipp, Matthias, Klausz, Katja
Publicado 2022

Generation and engineering of potent single domain antibody-based bispecific IL-18 mimetics resistant to IL-18BP decoy receptor inhibition

por Lipinski, Britta, Unmuth, Laura, Arras, Paul, Becker, Stefan, Bauer, Christina, Toleikis, Lars, Krah, Simon, Doerner, Achim, Yanakieva, Desislava, Boje, Ammelie Svea, Klausz, Katja, Peipp, Matthias, Siegmund, Vanessa, Evers, Andreas, Kolmar, Harald, Pekar, Lukas, Zielonka, Stefan
Publicado 2023

Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody

por Gehlert, Carina Lynn, Rahmati, Pegah, Boje, Ammelie Svea, Winterberg, Dorothee, Krohn, Steffen, Theocharis, Thomas, Cappuzzello, Elisa, Lux, Anja, Nimmerjahn, Falk, Ludwig, Ralf J., Lustig, Marta, Rösner, Thies, Valerius, Thomas, Schewe, Denis Martin, Kellner, Christian, Klausz, Katja, Peipp, Matthias
Publicado 2022